Advertisement

November 01, 2014

Volume 90Issue 3p477-720

Features

Point/Counterpoint

Clinical Investigations

Biology Contributions

Physics Contributions

Education and Practice

Comments

    Residual Tumor After Neoadjuvant Chemoradiation Outside the Radiation Therapy Target Volume: A New Prognostic Factor for Survival in Esophageal Cancer

    Definitive Primary Therapy in Patients Presenting With Oligometastatic Non-Small Cell Lung Cancer

Retraction

Advertisement